1. Introduction {#sec1-molecules-21-01702}
===============

*Periploca* is one of the genus in *Asclepiadaceae* family and is widely distributed in the north and tropical Africa, and East Asia \[[@B1-molecules-21-01702]\]. *Cortex Periplocae* has a special feature and shape. It presents as a roll or a groove, while a few of them appear as irregular blocks and flakes. The root is 3--12 cm long, 12 cm in diameter, 0.2--0.4 cm thick. The outer surface has a gray-brown or yellow-brown appearance that is rough and easy to peel. The inner surface shows a yellow or yellowish-brown color, with relatively smooth, easy to break, irregular sections with a yellow and white color. It has a specific aromatic smell, with those having a rough surface, thick skin, simple round shape, thick aroma, and bitter taste being the best choice. It thrives well on dry slopes, sandy ground, or hillsides. It mainly grows in Shanxi, Shandong, Henan, and Hebei province in China \[[@B2-molecules-21-01702]\]. *Cortex Periplocae* has a long history as Traditional Chinese Medicine (TCM) for the treatment of autoimmune diseases. It was first recorded in Shen Nong Ben Cao Jing 2000 years ago. Then, this plant was written about with different names in different classic books, such as "gangliupi" in *Kexuedeminjiancaoyao*, "chouwujia" in *Shandongzhongyao*, "shanwujiapi" in *Shanxizhongyaozhi*, and "xiangwujiapi" in *Sichuanzhongyaozhi*. Traditionally, *Cortex Periplocae* has been used to treat rheumatism and strengthen bones and tendons, and it is regarded as an effective tonic medicine \[[@B3-molecules-21-01702]\]. Currently, more than 100 compounds have been identified from *Cortex Periplocae*, some C~21~-steroidal glycosides and terpenoids have demonstrated special immunosuppressive activity \[[@B1-molecules-21-01702],[@B4-molecules-21-01702]\]. Besides its characteristic antirheumatic effect, it was shown to specifically treat heart failure. Research studies showed that the extracts of *Cortex Periplocae* exhibited cardiotonic effects on the isolated heart of rats and could strengthen cardiotonic function \[[@B5-molecules-21-01702],[@B6-molecules-21-01702]\]. In addition, more studies have been focused on its antitumoral effect. Studies reported that *Cortex Periplocae* showed a good effect on tumor cell apoptosis and the repression of tumor growth of SW480 cells, TE-13 cells, SMMC-7721 cells, MCF-7 cells, BGC-823 cells, etc. \[[@B2-molecules-21-01702],[@B7-molecules-21-01702],[@B8-molecules-21-01702]\]. However, poisoning incidences caused by using *Cortex Periplocae* have also been reported. As it is well known, periplocin is a poisonous component in *Cortex Periplocae*, and it shows a special cardiotoxic effect. Sun et al. studied the LD~50~ value of periplocin in mice and determined that it was 15.20 mg/kg by intraperitoneal injection. Studies also showed that it could obviously affect the electrocardiograms of guinea pigs, which indicated that it had a special toxicity \[[@B9-molecules-21-01702]\]. It was also found that there was a good correlation between the content of periplocin and the acute toxicity of *Cortex Periplocae*. It implied that the content of periplocin should be limited in order to reduce the toxicity response when it was used in clinic \[[@B10-molecules-21-01702]\].

Numerous components have been identified from this herb, and some of them have been proven to have an effective function for the treatment of different diseases for many years. Here, we summarized the available articles about the photochemistry, biological activities, and toxicity profile of *Cortex Periplocae*.

2. Methods {#sec2-molecules-21-01702}
==========

All the information about this plant has been obtained through searching journals, books, and theses and collected via libraries or electronic databases including PubMed, Elsevier, Google Scholar, and Springer. Due to few publications of this herb in English literature, the main source of information of this plant was from China national knowledge infrastructure (CNKI) and other classic Chinese herbal literature.

3. Phytochemistry {#sec3-molecules-21-01702}
=================

Many chemical constituents and active ingredients have been isolated from *Cortex Periplocae*, since the 1970s by researchers \[[@B11-molecules-21-01702]\]. So far, more than 100 compounds have been isolated and identified from this plant, containing C~21~-steroidal glycosides, cardiac glycosides, terpenoids, volatile oils, fatty acids, etc.

3.1. C~21~-Steroidal Glycosides {#sec3dot1-molecules-21-01702}
-------------------------------

C~21~-steroidal glycosides account for the majority of the total chemical constituents of *Cortex Periplocae*. There are more than 30 C~21-~steroidal glycosides which have been identified from *Cortex Periplocae* ([Figure 1](#molecules-21-01702-f001){ref-type="fig"}, [Table 1](#molecules-21-01702-t001){ref-type="table"}). These steroids have five essential C~21~ skeletons and their respective glycosides, including β-[d]{.smallcaps}-glucopyranosyl (Glc), β-cymaropyranosyl (Cym), β-canaropyranosyl (Can), and β-digitalopyranosyl (Dig).

3.2. Cardiac Glycosides {#sec3dot2-molecules-21-01702}
-----------------------

Another type of compound contained in this plant is cardiac components, including two glycosides and two aglycones, which were identified as periplocin, peripocymarin, periplogenin, and xysmalogenin \[[@B23-molecules-21-01702]\]. Research reported that periplocin was a special ingredient, which was not only a cardiotonic compound, but also the main toxic component in *Cortex Periplocae* \[[@B5-molecules-21-01702]\]. Therefore, it is necessary to develop more studies for the assessment of toxicity of periplocin in order to guarantee efficacy and safety when it is utilized in clinic. The chemical structures of these four constituents are shown in [Figure 2](#molecules-21-01702-f002){ref-type="fig"}. [Table 2](#molecules-21-01702-t002){ref-type="table"} lists the compounds, plant parts used, and references.

3.3. Fatty Acids and Volatile Oils {#sec3dot3-molecules-21-01702}
----------------------------------

Li et al. \[[@B25-molecules-21-01702]\] analyzed the fatty acid compositions in the *Cortex Periplocae* extract using a gas chromatography-mass spectrometer, and identified 14 types of fatty acids (40--53), mainly including palmitic acid, linoleic acid, oleic acid, and linolenic acid. Shi et al. isolated 15 types of volatile oils (57--66) from *Cortex Periplocae* and 10 of them were purified and identified \[[@B26-molecules-21-01702]\]. Moreover, other researchers \[[@B27-molecules-21-01702]\] also found several different fatty acids and volatile oils in *Cortex Periplocae* ([Figure 3](#molecules-21-01702-f003){ref-type="fig"}, [Table 3](#molecules-21-01702-t003){ref-type="table"}). 4-methoxysalicylaldehyde has a unique fragrance and expresses antimicrobial and antioxidant activities \[[@B28-molecules-21-01702]\]. It can be deemed suitable as a standard in evaluating the quality of this plant \[[@B29-molecules-21-01702]\].

3.4. Terpenoids {#sec3dot4-molecules-21-01702}
---------------

Just like some other herbs, a small number of terpenoids were isolated from *Cortex Periplocae*. In 1971, Mitsuhash et al. found ursolic acid, oleanolic acid, lupeol, and lupeol acetate in *Cortex Periplocae* \[[@B31-molecules-21-01702]\]. Furthermore, hederagenin, α-amyrinacetate, β-amyrinacetate, α-amyrin, β-amyrin, and scopoletin were identified in *Cortex Periplocae*. Later, (24*R*)-9,19-cycloart-25-ene-3β,24-diol, (24*S*)-9,19-cycloart-25-ene-3β,24-diol, and cycloeucalenol were isolated from the ethyl acetate extracts of *Cortex Periplocae* ([Table 4](#molecules-21-01702-t004){ref-type="table"}, [Figure 4](#molecules-21-01702-f004){ref-type="fig"}).

3.5. Others {#sec3dot5-molecules-21-01702}
-----------

In addition, other chemical constituents also exist in *Cortex Periplocae*, including saccharides, aldehydes, flavonoids, etc. ([Table 5](#molecules-21-01702-t005){ref-type="table"}, [Figure 5](#molecules-21-01702-f005){ref-type="fig"}).

4. Pharmacokinetics {#sec4-molecules-21-01702}
===================

Studies on the pharmacokinetics (PK) of *Cortex Periplocae* are somewhat limited. Available literature mainly focused on its toxic component, periplocin. There is a report on the PK study of periplocin with its two metabolites (periplocymarin and periplogenin) in rat plasma and periplogenin in rat plasma. He et al. \[[@B6-molecules-21-01702]\] studied the PK of *Cortex Periplocae* in rat's serum. This was studied to determine the concentrations of periplocin and two metabolites simultaneously in rats' plasma by using LC-MS/MS. The rats were given 50 mg/kg periplocin dissolved in water by gavage. As shown from the results, they found that the concentration of periplocin could only be detected at a few time points; however, its two metabolites (periplocymarin and periplogenin) reached the maximum plasma concentration after 8--10 h. The Cmax for periplocymarin and periplogenin were 1655.63 ± 404.26 ng/mL and 32.94 ± 9.16 ng/mL, respectively. Furthermore, research was done using the same method coupled with high performance liquid chromatography tandem mass spectrometry to validate the quantifying method of periplogenin in rat plasma using psoralen as an internal standard (IS) \[[@B48-molecules-21-01702]\]. All these studies provided the pharmacokinetics (PK) information of the toxic compounds in *Cortex Periplocae*. We can better know its physiological disposition, which might be helpful for its application in clinical therapy.

5. Pharmacology {#sec5-molecules-21-01702}
===============

Recently, various studies indicate that *Cortex Periplocae* shows wide pharmacological activities, including anti-inflammatory, antitumor, cardiotonic action, nervous system action, cell differentiation, and insecticidal action, indicating that it has more potential to be discovered.

5.1. Anti-Inflammatory Activity {#sec5dot1-molecules-21-01702}
-------------------------------

*Cortex Periplocae*, a Traditional Chinese Medicine, is widely used to treat rheumatoid arthritis in China. Based on its traditional usage, more studies are projected to find its active compounds. Tokiwa et al. verified that the aqueous extract of *Cortex Periplocae* dose-dependently inhibited the growth and IL-6 production of synovial fibroblast-like cells, which showed a good effect for cytokines \[[@B49-molecules-21-01702]\]. Zhu et al. used bioactivity-guided isolation to screen anti-inflammatory compounds from *Cortex Periplocae* \[[@B50-molecules-21-01702]\]. They found that periplocoside E could significantly inhibit T cell activation in vitro and in vivo. Administration of periplocoside E suppressed ovalbumin induced proliferation and cytokine (interleukin (IL)-2 and interferon (IFN)-γ) production of splenocytes in dose-dependent manners. Further studies showed that periplocoside E also inhibited anti-CD3-induced primary T cell proliferation, cytokine (IFN-γ and IL-2) production, and IL-2Rα (CD25) expression. Periplocoside A was another active compound identified from *Cortex Periplocae*. Periplocoside A could significantly suppress IL-4 transcription and IFN-γ translation, which further protected humans from autoimmune-related hepatitis \[[@B51-molecules-21-01702]\]. These components may be responsible for the therapeutic effects of *Cortex Periplocae*. These results demonstrated that there was evidence for using *Cortex Periplocae* to treat autoimmune diseases. Furthermore, Gu et al. investigated that periplogenin could inhibit histamine release of mast cells cultured in vitro and in antigen-sensitized rats in an obvious dose-dependent manner \[[@B4-molecules-21-01702]\]. Therefore, it was inferred that periplogenin should be one of the active compounds in *Cortex Periplocae*, producing its anti-inflammatory effects.

5.2. Antitumor Activity {#sec5dot2-molecules-21-01702}
-----------------------

Recently, many active screening results have indicated that *Cortex Periplocae* has antitumor activities. Du et al. used different concentrations of periplocin to determine the inhibitory effects on the proliferation of SW480 cells and observe the survival expression in SW480 cells after administering periplocin. The results showed that periplocin could significantly induce the apoptosis of SW480 cells. The SW480 cells showed some typical morphological features and microstructural changes after treating them with periplocin. Moreover, the expression of survival in SW480 cells was also inhibited after treatment with periplocin. From the results, they found the periplocin identified from *Cortex Periplocae* significantly inhibited the proliferation of SW480 cells. They further detected the expression of some signaling pathways involved in Wnt/β-catenin after treatment with periplocin, these signaling pathways in transplanted tumor were significantly lower, which was related with the inhibiting effect of the Wnt/β-catenin signaling pathway \[[@B52-molecules-21-01702],[@B53-molecules-21-01702]\]. Zhang et al. found that periplocin inhibited the proliferation of SMMC-7721 cells and arrested them at the G2/M phase by inhibiting Stat3 signal transduction in human hepatic cells \[[@B54-molecules-21-01702]\]. As a potential antitumor component, periplocin also showed an inhibition effect on BT-549 and TE-13, which suppressed proliferation and induced apoptosis of these cells significantly \[[@B55-molecules-21-01702],[@B56-molecules-21-01702]\]. On the other hand, research showed that some flavonoids in *Cortex Periplocae* could inhibit the proliferation of cancer cells. For example, baohuoside I could inhibit the proliferation of Eca-109 cells in vivo and in vitro \[[@B41-molecules-21-01702]\]. The in vitro and in vivo studies of the antitumor activity of *Cortex Periplocae* could show some potential effects to help people deal with tumors in the future.

5.3. Cardiotonic Action {#sec5dot3-molecules-21-01702}
-----------------------

In this plant's traditional usages, one important application is cardiotonic action. The main compounds exhibiting cardiotonic action are cardiac glycosides. Li et al. used the isolated heart perfusion technique to evaluate the cardiotonic action of *Cortex Periplocae* \[[@B57-molecules-21-01702]\]. The study of Li et al. indicated the *Cortex Periplocae* extracts significantly increased LVSP and decreased LVEDP, which demonstrated that *Cortex Periplocae* may have a cardiac effect. Ma et al. found periplocin could improve the structure and function of the left ventricle in chronic heart failure in rats \[[@B58-molecules-21-01702]\]. Xie et al. proposed that cardiotonic glycosides shared the capacity to bind to the extra-cellular surface of the main ion transport protein in the cell \[[@B59-molecules-21-01702]\]. Therefore, the mechanism of its cardiotonic action is should be explored to promote clinical administration.

5.4. Effects on the Nervous System {#sec5dot4-molecules-21-01702}
----------------------------------

Sakuma et al. suggested that glycoside K, glycoside H1, and glycoside H2 which were identified from the *Cortex Periplocae* show strong potentiation of NGF-mediated nerve fiber outgrowth in chicken embryonic dorsal root and sympathetic ganglia, especially glycoside H2. These glycosides were consequently expected to have an impressive effect on the neuronal system \[[@B18-molecules-21-01702]\].

5.5. Insecticidal Action {#sec5dot5-molecules-21-01702}
------------------------

Zhao et al. isolated a highly potent insecticidal compound---called periplocoside NW (PSNW)---from *Cortex Periplocae* by bioactivity-guided screening method \[[@B60-molecules-21-01702]\]. They found cell damage was caused by PSNW in the midgut of *Mythimna separata* larvae. The results of insecticidal bioassay and immunoelectron microscopic localization showed that some gold particles appeared on the microvilli layer of the midgut of *M. separata* larvae, and accumulated gradually over time until it was destroyed. Therefore, they concluded that the mechanism might be related to the degeneration of brush border microvilli, and finally periplocoside NW was applied against insects. Shi et al. found that *n*-butyl alcohol extracts from *Cortex Periplocae* could kill *Sohizaphis graminum* effectively and possessed some stomach poison against *Mythimna separata* larvae. Hui et al. separated some active components from *Periploca* methyl alcohol extraction, which exhibited significant repellent activity for *Soknopsis invicta* \[[@B61-molecules-21-01702],[@B62-molecules-21-01702]\].

6. Clinic Application {#sec6-molecules-21-01702}
=====================

6.1. Antirheumatic Effect {#sec6dot1-molecules-21-01702}
-------------------------

From time immemorial, *Cortex Periplocae* has been regarded as an available medicine to treat rheumatism. Because of its peculiarity, it is used as an external preparation, such as Huoxuezhitong sticking and Tianhezhuifeng sticking. Additionally, some medicinal liquors including *Cortex Periplocae* show distinct antirheumatic action.

6.2. Chronic Congestive Heart Failure Action {#sec6dot2-molecules-21-01702}
--------------------------------------------

Extraction of *Cortex Periplocae* was made into tablets, 10 mg per tablet, oral administration three times a day for four or five days. In a 21 case study, 12 cases were found to be remarkable effective. It can be found that *Cortex Periplocae* has an effective action to treat chronic congestive heart failure \[[@B5-molecules-21-01702]\].

7. Toxicity {#sec7-molecules-21-01702}
===========

Based on the traditional Chinese medicine classes, *Cortex Periplocae* is prudently recorded as a toxic medicine. *Sichuanzhongyaozhi* labeled it as "toxic, not appropriate to use for long time". It is obvious that people long ago recognized the toxicity of *Cortex Periplocae*. Sun et al. found that all components, water extraction components, and alcohol extraction components of *Cortex Periplocae* showed the acute toxicity on mice \[[@B63-molecules-21-01702]\]. Furthermore, through accumulative toxicity experiments, rats indicated serious reactions under a large dosage of *Cortex Periplocae* extraction \[[@B64-molecules-21-01702]\]. Many conditions may cause intoxication such as over-dosage, drug confusion, incompatibility with herbs, and improper decoction causing life-threatening complications. Hence, it is necessary to normalize its dosage and administration.

In the Chinese Pharmacopoeia, the dosage of "xiangjiapi" ranges from 3 g/60 kg/day to 6 g/60 kg/day. Periplocin is its main toxic component, which can express cardiotonic action with unsuitable dosages. In the usual application, people always notice its great tonic effect, but not its potential toxicity. Although Tong et al. established an RP-HPLC method to determine the content of periplocin, due to extreme differences of periplocin content in *Cortex Periplocae* from different provinces, it is difficult to control toxic effects \[[@B65-molecules-21-01702]\]. In recent years, many adverse events have often occurred. The toxic ingredients are also the effective constituents, so there is a need to strengthen knowledge about using this herb to prevent adverse outcomes. This will be beneficial in guiding reasonable clinical prescription.

8. Conclusions {#sec8-molecules-21-01702}
==============

As a traditional Chinese herbal medicine, *Cortex Periplocae* has been widely used to treat autoimmune diseases, especially rheumatoid arthritis. In the field of phytochemistry, it is reported to contain many compounds, including pregnane glycosides, steroids, volatile oils, polysaccharides, fatty acids, and cardiac glycosides. Although more than 100 compounds were obtained from this herb, further systematic phytochemistry research should be conducted. In the study of pharmacology, the extracts and chemical components from this plant focused on anti-inflammatory, antitumor, and immune functions. Although many chemical constituent analyses and pharmacological activity studies of this herb have been reported, the pharmacological mechanism of action and the metabolites responsible for these activities should be studied further. In addition, *Cortex Periplocae* was proven to be toxic in its clinical application; while its cardiotonic components are useful for the treatment of heart failure. Therefore, clarifying the mechanism, ensuring effectiveness, and minimizing risk are of great significance to more effective utilization of *Cortex Periplocae*. More studies should be carried out and methods should be developed to ensure an effective therapeutic effect with minimal toxicity in clinical applications.
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molecules-21-01702-t001_Table 1

###### 

C~21~-steroidal glycosides from *Cortex Periplocae* (1--35).

  No.   Compound's Name                                                                                                                                                                                                                                                              Parts Used   Reference
  ----- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------ --------------------------------------------------------
  1     Periplocoside A                                                                                                                                                                                                                                                              Root         \[[@B1-molecules-21-01702],[@B12-molecules-21-01702]\]
  2     Periplocoside B                                                                                                                                                                                                                                                              Root         \[[@B1-molecules-21-01702],[@B12-molecules-21-01702]\]
  3     Periplocoside C                                                                                                                                                                                                                                                              Root         \[[@B1-molecules-21-01702],[@B12-molecules-21-01702]\]
  4     Periplocoside D                                                                                                                                                                                                                                                              Root         \[[@B1-molecules-21-01702],[@B13-molecules-21-01702]\]
  5     Periplocoside E                                                                                                                                                                                                                                                              Root         \[[@B1-molecules-21-01702],[@B13-molecules-21-01702]\]
  6     Periplocoside F                                                                                                                                                                                                                                                              Root         \[[@B14-molecules-21-01702]\]
  7     Periplocoside J                                                                                                                                                                                                                                                              Root         \[[@B14-molecules-21-01702]\]
  8     Periplocoside K                                                                                                                                                                                                                                                              Root         \[[@B14-molecules-21-01702]\]
  9     Periplocoside L                                                                                                                                                                                                                                                              Root         \[[@B1-molecules-21-01702],[@B13-molecules-21-01702]\]
  10    Periplocoside M                                                                                                                                                                                                                                                              Root         \[[@B1-molecules-21-01702],[@B13-molecules-21-01702]\]
  11    Periplocoside O                                                                                                                                                                                                                                                              Root         \[[@B14-molecules-21-01702]\]
  12    Glycoside E                                                                                                                                                                                                                                                                  Root         \[[@B15-molecules-21-01702]\]
  13    Glycoside K                                                                                                                                                                                                                                                                  Root         \[[@B15-molecules-21-01702]\]
  14    Glycoside H1                                                                                                                                                                                                                                                                 Root         \[[@B15-molecules-21-01702]\]
  15    Periplocogenin                                                                                                                                                                                                                                                               Root         \[[@B1-molecules-21-01702],[@B16-molecules-21-01702]\]
  16    Δ5-pregnene-3β,20α-diol                                                                                                                                                                                                                                                      Root         \[[@B11-molecules-21-01702]\]
  17    Δ5-pregnene-3β,17α,20α-triol                                                                                                                                                                                                                                                 Root         \[[@B11-molecules-21-01702]\]
  18    Δ5-pregnene-3β,20(*S*)-diol 3-*O*-\[β-[d]{.smallcaps}-digitalopyranosyl (1→4)β-[d]{.smallcaps}-cymaropyranoside\]20-*O*-\[β-[d]{.smallcaps}-glucopyranosyl (1→6)-β-[d]{.smallcaps}-glucopyranosyl (1→2)-β-[d]{.smallcaps}-digitalopyranoslde\](*S*-5)                        Root         \[[@B17-molecules-21-01702]\]
  19    *S*-20                                                                                                                                                                                                                                                                       Root         \[[@B14-molecules-21-01702]\]
  20    Glycoside H~2~                                                                                                                                                                                                                                                               Root         \[[@B18-molecules-21-01702]\]
  21    Plocoside A                                                                                                                                                                                                                                                                  Root         \[[@B19-molecules-21-01702]\]
  22    Plocoside B                                                                                                                                                                                                                                                                  Root         \[[@B19-molecules-21-01702]\]
  23    Δ5-pregnene-3β,16β,20(*R*)-triol-3-*O*-\[2,-*O*-acetyl-β-[d]{.smallcaps}-digitalopyranosyl (1→4)-β-[d]{.smallcaps}-cymaropyranoside\]20-*O*-\[β-[d]{.smallcaps}-glucopyranosyl (1→6)-β-[d]{.smallcaps}-glucopyranosyl (1→2)-β-[d]{.smallcaps}-digitalopyranoslde\](*S*-4a)   Root         \[[@B17-molecules-21-01702]\]
  24    Δ5-pregnene-3β,16β,20(*R*)-trio1 20-*O*-β-[d]{.smallcaps}-glucopyranosyl (1→6)-β-[d]{.smallcaps}-glucopyranosyl (1→2)-β-[d]{.smallcaps}-digitalopyranoslde(*S*-10)                                                                                                           Root         \[[@B17-molecules-21-01702]\]
  25    Δ5-pregnene-3β,16α,20α-triol                                                                                                                                                                                                                                                 Root         \[[@B20-molecules-21-01702]\]
  26    21-*O*-methyl-Δ5-pregnene-3β,14β,17β,21-tetraol-20-one(Compound Ia)                                                                                                                                                                                                          Root         \[[@B21-molecules-21-01702]\]
  27    21-*O*-methyl-5-pregnene-3β,14β,17β,20,21-pentaol(Compound 1)                                                                                                                                                                                                                Root         \[[@B21-molecules-21-01702]\]
  28    21-*O*-methyl-5,14-pregndlene-3β,l7β,20,21-tetraol(Compound 2)                                                                                                                                                                                                               Root         \[[@B21-molecules-21-01702]\]
  29    12β-hydroxypregna-4,6,16-triene-3,20-dione (*S*-I)                                                                                                                                                                                                                           Root         \[[@B16-molecules-21-01702]\]
  30    Periseosides A                                                                                                                                                                                                                                                               Root         \[[@B22-molecules-21-01702]\]
  31    Periseosides B                                                                                                                                                                                                                                                               Root         \[[@B22-molecules-21-01702]\]
  32    Periseosides C                                                                                                                                                                                                                                                               Root         \[[@B22-molecules-21-01702]\]
  33    Periseosides D                                                                                                                                                                                                                                                               Root         \[[@B22-molecules-21-01702]\]
  34    Periseosides E                                                                                                                                                                                                                                                               Root         \[[@B22-molecules-21-01702]\]
  35    Periperoxide A                                                                                                                                                                                                                                                               Root         \[[@B1-molecules-21-01702]\]

molecules-21-01702-t002_Table 2

###### 

Cardiac glycosides from *Cortex Periplocae* (36--39).

  No.   Compound's Name   Parts Used   Reference
  ----- ----------------- ------------ -------------------------------
  36    Periplocin        Root         \[[@B24-molecules-21-01702]\]
  37    Periplogenin      Root         \[[@B1-molecules-21-01702]\]
  38    Periplocymarin    Root         \[[@B1-molecules-21-01702]\]
  39    Xysmalogenin      Root         \[[@B11-molecules-21-01702]\]

molecules-21-01702-t003_Table 3

###### 

Fatty acids and volatile oils from *Cortex Periplocae* (40--76).

  No.   Compound's Name                                Parts Used   Reference
  ----- ---------------------------------------------- ------------ -------------------------------
  40    Azelaicacid                                    Root         \[[@B25-molecules-21-01702]\]
  41    Myristic acid                                  Root         \[[@B25-molecules-21-01702]\]
  42    Pentadecanoicacid                              Root         \[[@B25-molecules-21-01702]\]
  43    Palmitic acid                                  Root         \[[@B25-molecules-21-01702]\]
  44    Palmitoleic acid                               Root         \[[@B25-molecules-21-01702]\]
  45    Stearic acid                                   Root         \[[@B25-molecules-21-01702]\]
  46    Oleicacid                                      Root         \[[@B25-molecules-21-01702]\]
  47    Docosanoicacid                                 Root         \[[@B25-molecules-21-01702]\]
  48    Docosatetraenoic acid                          Root         \[[@B25-molecules-21-01702]\]
  49    Arachidic acid                                 Root         \[[@B25-molecules-21-01702]\]
  50    4-Methylsalicylic acid                         Root         \[[@B25-molecules-21-01702]\]
  51    Linoleicacid                                   Root         \[[@B25-molecules-21-01702]\]
  52    α-Linolenic acid                               Root         \[[@B25-molecules-21-01702]\]
  53    Eicosatetraenoic acid                          Root         \[[@B25-molecules-21-01702]\]
  54    Eicosatrienoic acid                            Root         \[[@B27-molecules-21-01702]\]
  55    Eicosandienoic acid                            Root         \[[@B27-molecules-21-01702]\]
  56    *n*-octenoic acid                              Root         \[[@B27-molecules-21-01702]\]
  57    Butyl acetate                                  Root         \[[@B26-molecules-21-01702]\]
  58    4-methyl-2-pentanone                           Root         \[[@B26-molecules-21-01702]\]
  59    *n*-Butyl ether                                Root         \[[@B26-molecules-21-01702]\]
  60    Butyl formate                                  Root         \[[@B26-molecules-21-01702]\]
  61    1-(1-ethoxyethoxy)-butane                      Root         \[[@B26-molecules-21-01702]\]
  62    *S*-(8-(diethylphosphono)octyl)ethanethioate   Root         \[[@B26-molecules-21-01702]\]
  63    2-methyl-1,3-dioxy-cyclopentyl-ethyl acetate   Root         \[[@B26-molecules-21-01702]\]
  64    2-butoxytetrahydropyran                        Root         \[[@B26-molecules-21-01702]\]
  65    1,1,3,3-tetrabutoxy-2-propanone                Root         \[[@B26-molecules-21-01702]\]
  66    4-methoxysalicylaldehyde                       Root         \[[@B26-molecules-21-01702]\]
  67    Benzaldehyde                                   Root         \[[@B27-molecules-21-01702]\]
  68    1-methoxyl-4-(2-ProPenyl)-benzene              Root         \[[@B27-molecules-21-01702]\]
  69    1,2-dimethoxyl-4-(2-propenyl)-benzene          Root         \[[@B27-molecules-21-01702]\]
  70    Isovanillin                                    Root         \[[@B27-molecules-21-01702]\]
  71    Vanillin                                       Root         \[[@B30-molecules-21-01702]\]
  72    9-methyl-tetradecanoic acid                    Root         \[[@B27-molecules-21-01702]\]
  73    *n*-pentadecanoic acid                         Root         \[[@B27-molecules-21-01702]\]
  74    Heptadecenoic acid                             Root         \[[@B27-molecules-21-01702]\]
  75    8-octadecenoic acid                            Root         \[[@B27-molecules-21-01702]\]
  76    Hexadecenoic acid                              Root         \[[@B27-molecules-21-01702]\]

molecules-21-01702-t004_Table 4

###### 

Terpenoids from *Cortex Periplocae* (77--88).

  No.   Compound's Name                           Parts Used   Reference
  ----- ----------------------------------------- ------------ -------------------------------
  77    α-amyrinacetate                           Root         \[[@B32-molecules-21-01702]\]
  78    β-amyrinacetate                           Root         \[[@B33-molecules-21-01702]\]
  79    α-amyrin                                  Root         \[[@B34-molecules-21-01702]\]
  80    β-amyrin                                  Root         \[[@B35-molecules-21-01702]\]
  81    Lupeol acetate                            Root         \[[@B32-molecules-21-01702]\]
  82    Ursolicacid                               Root         \[[@B31-molecules-21-01702]\]
  83    Oleanolicacid                             Root         \[[@B31-molecules-21-01702]\]
  84    Hederagenin                               Root         \[[@B36-molecules-21-01702]\]
  85    Lupeol                                    Root         \[[@B37-molecules-21-01702]\]
  86    Cycloeucalenol                            Root         \[[@B38-molecules-21-01702]\]
  87    (24*S*)-9,19-cycloart-25-ene-3β,24-diol   Root         \[[@B39-molecules-21-01702]\]
  88    (24*R*)-9,19-cycloart-25-ene-3β,24-diol   Root         \[[@B39-molecules-21-01702]\]

molecules-21-01702-t005_Table 5

###### 

Others components from *Cortex Periplocae* (89--108).

  No.   Compound's Name                                                                                      Parts Used   Reference
  ----- ---------------------------------------------------------------------------------------------------- ------------ -------------------------------
  89    Perisaccharide A                                                                                     Root         \[[@B1-molecules-21-01702]\]
  90    Perisaccharide B                                                                                     Root         \[[@B1-molecules-21-01702]\]
  91    Perisaccharide C                                                                                     Root         \[[@B1-molecules-21-01702]\]
  92    Oligosaccharides C~1~                                                                                Root         \[[@B40-molecules-21-01702]\]
  93    Oligosaccharides D~2~                                                                                Root         \[[@B40-molecules-21-01702]\]
  94    Oligosaccharides F~2~                                                                                Root         \[[@B40-molecules-21-01702]\]
  95    Oligosaccharides F~1~                                                                                Root         \[[@B40-molecules-21-01702]\]
  96    β-sitosterol                                                                                         Root         \[[@B11-molecules-21-01702]\]
  97    Baohuoside I                                                                                         Root         \[[@B41-molecules-21-01702]\]
  98    Daucosterol                                                                                          Root         \[[@B42-molecules-21-01702]\]
  99    Tortoside B                                                                                          Root         \[[@B43-molecules-21-01702]\]
  100   Limonin                                                                                              Root         \[[@B44-molecules-21-01702]\]
  101   Proanthocyandin B~2~                                                                                 Root         \[[@B45-molecules-21-01702]\]
  102   Ethyl caffeate                                                                                       Root         \[[@B43-molecules-21-01702]\]
  103   Scopoletin                                                                                           Root         \[[@B46-molecules-21-01702]\]
  104   4-Methoxybenzaldehyde                                                                                Root         \[[@B20-molecules-21-01702]\]
  105   4-*O*-(2-*O*-acetyl-β-[d]{.smallcaps}-digitalopyranosyl)-[d]{.smallcaps}-cymaropyranose              Root         \[[@B47-molecules-21-01702]\]
  106   Methyl-4-*O*-(2-*O*-acetyl-β-[d]{.smallcaps}-digitalopyranosyl)-β-[d]{.smallcaps}-cymaropyranoside   Root         \[[@B47-molecules-21-01702]\]
  107   Vanillin lactose glycolsides                                                                         Root         \[[@B33-molecules-21-01702]\]
  108   β-sitosterol-β-[d]{.smallcaps}-glucoside                                                             Root         \[[@B11-molecules-21-01702]\]
